|
Anu’s Laboratories |
|
|
Period |
05-Dec to 04-May 2008 |
|
Size (Equity Shares) |
38,20,000 |
|
Type |
100% Book Building |
|
Face Value |
Rs. 10- |
|
Price Range |
Rs 200 to Rs 210 |
|
Market Lot |
|
|
Max shares Retails investor can apply at cut off |
|
|
Registrar |
Karvy Computershare Pvt Ltd |
|
Registrar’s email |
einward.ris@karvy.com |
|
Lead Manager |
Almondz Global Securities Ltd |
|
Listing |
BSE, NSE |
|
Grading |
|
|
About the company |
|
|
Incorporated: 1996. Bulk active pharma ingredients and intermediates for drug molecules. Produce Dichloro-5-Fluoro Acetophenone, or DCFA, a key intermediate for ciprofloxacin. 60% market share in the country |
|
|
Objects of the Issue |
|
|
Set up an intermediary plant and contract research facility at Pharma City in Visakhapatnam |
|
Anu’s Laboratories
May 4th, 2008 · No Comments
Tags: IPO

0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment